BioSpace News Archive

Linnaeus Therapeutics, Inc. (Linnaeus) today announced that on June 28, 2022 the U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,369,618 (‘618 patent) entitled “Compounds, Compositions Methods for Prevention and/or Treatment of Cancer”.

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced that the Company will participate in a panel discussion and host 1x1 meetings at the upcoming Cantor Oncology, Hematology, HemeOnc Conference.

Alafair Biosciences, the leader in non-collagenous soft tissue protection technology, today announced it has enrolled the first patient in a clinical study of the VersaWrap device on hand tendon repair and tenolysis procedures.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced two presentations on RADICAVA ORS® (edaravone) in amyotrophic lateral sclerosis (ALS) will be shared at the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, being held in Nashville, Tenn., from September 21-24.

Scientific Industries, Inc. announced that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking place virtually on September 28-29, 2022.

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that management will participate in Ladenburg Thalmann’s 2022 Healthcare Conference on September 29, 2022 at the Sofitel New York.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today announced it has begun enrollments in a large-scale blood loss detection clinical trial with its second-generation monitoring system, the CM-1600.